Highly resistant Salmonella enterica serovar typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 5, 2012, Pages 2761-2762

  Koirala, Kanika Deshpande ^a   Thanh, Duy Pham ^a   Thapa, Sudeep Dhoj ^a   Arjyal, Amit ^a   Karkey, Abhilasha ^a   Dongol, Sabina ^a   Shrestha, Upendra Man ^a   Farrar, Jeremy J ^a,b   Basnyat, Buddha ^a   Baker, Stephen ^a,b  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; OFLOXACIN; QUINOLONE DERIVATIVE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; CASE REPORT; DRUG DOSE INCREASE; DRUG EFFICACY; GENE MUTATION; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHI; TREATMENT FAILURE; TYPHOID FEVER; TYPHOID RESISTANCE;

EID: 84860149893     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06414-11     Document Type: Article

References (10)

1. Chau TT, et al. 2007. Antimicrobial drug resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob. Agents Chemother. 51: 4315-4323. (Pubitemid 350209883)
2. Chuang CH, et al. 2009. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol. Infect. 137:266-269.
3. Dolecek C, et al. 2008. A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS One 3:e2188.
4. Dutta S, et al. 2008. Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India. Int. J. Antimicrob. Agents 31:387-389.
5. Le TM, et al. 2009. High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City, Vietnam. J. Med. Microbiol. 58:1585-1592.
6. Parry CM, Threlfall EJ. 2008. Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Curr. Opin. Infect. Dis. 21:531-538.
7. Parry CM, et al. 2010. Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones. Antimicrob. Agents Chemother. 54: 5201-5208.
8. Parry CM, et al. 2011. The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy. PLoS Negl. Trop. Dis. 5:e1163.
9. Smith AM, Govender N, Keddy KH. 2010. Quinolone-resistant Salmonella Typhi in South Africa, 2003-2007. Epidemiol. Infect. 138:86-90.
10. World Health Organization. 2003. Background document: the diagnosis, treatment and prevention of typhoid fever. WHO/V&B/03.07. World Health Organization, Geneva, Switzerland.